Kenvue Inc.’s latest results show a moving target in the section of its business needing attention to spur sales growth as sales of the Listerine line and other essential health products dropped 4.1% in the fourth quarter while skin health and beauty product sales recovered to show slight growth.
China Distribution Disruption Drags Kenvue Results
Activist Investor Starboard Files Nominations For Four Board Seats
CEO Thibaut Mongon says Kenvue’s results for current quarter will be affected by “lingering impact of the distribution disruption we saw in China,” which “will take a little bit of time to fix.” Also, activist investor Starboard wants to bring “significant changes” to the board at firm’s annual shareholder meeting later in year.
